NEW YORK, Jan. 18, 2023 /PRNewswire/ — Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Leap Therapeutics, Inc. (“Leap” or the “Company”) (NASDAQ: LPTX), in connection with the proposed purchase of Flame Biosciences,…
SHAREHOLDER ALERT: Weiss Law Investigates Leap Therapeutics, Inc.
Technology and Entertainment Magazine
Contact us
renewsindustry@gmail.com
+92 318 3083960